BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18632612)

  • 1. Genomic alterations indicate tumor origin and varied metastatic potential of disseminated cells from prostate cancer patients.
    Holcomb IN; Grove DI; Kinnunen M; Friedman CL; Gallaher IS; Morgan TM; Sather CL; Delrow JJ; Nelson PS; Lange PH; Ellis WJ; True LD; Young JM; Hsu L; Trask BJ; Vessella RL
    Cancer Res; 2008 Jul; 68(14):5599-608. PubMed ID: 18632612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.
    Cher ML; Bova GS; Moore DH; Small EJ; Carroll PR; Pin SS; Epstein JI; Isaacs WB; Jensen RH
    Cancer Res; 1996 Jul; 56(13):3091-102. PubMed ID: 8674067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analyses of chromosome alterations in soft-tissue metastases within and across patients with castration-resistant prostate cancer.
    Holcomb IN; Young JM; Coleman IM; Salari K; Grove DI; Hsu L; True LD; Roudier MP; Morrissey CM; Higano CS; Nelson PS; Vessella RL; Trask BJ
    Cancer Res; 2009 Oct; 69(19):7793-802. PubMed ID: 19773449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Resolution Genomic Profiling of Disseminated Tumor Cells in Prostate Cancer.
    Wu Y; Schoenborn JR; Morrissey C; Xia J; Larson S; Brown LG; Qu X; Lange PH; Nelson PS; Vessella RL; Fang M
    J Mol Diagn; 2016 Jan; 18(1):131-43. PubMed ID: 26607774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic changes in clinically organ-confined prostate cancer by comparative genomic hybridization.
    Fu W; Bubendorf L; Willi N; Moch H; Mihatsch MJ; Sauter G; Gasser TC
    Urology; 2000 Nov; 56(5):880-5. PubMed ID: 11068328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer.
    Cher ML; MacGrogan D; Bookstein R; Brown JA; Jenkins RB; Jensen RH
    Genes Chromosomes Cancer; 1994 Nov; 11(3):153-62. PubMed ID: 7530484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and isolation of disseminated tumor cells in bone marrow of patients with clinically localized prostate cancer.
    Cackowski FC; Wang Y; Decker JT; Sifuentes C; Weindorf S; Jung Y; Wang Y; Decker AM; Yumoto K; Szerlip N; Buttitta L; Pienta KJ; Morgan TM; Taichman RS
    Prostate; 2019 Oct; 79(14):1715-1727. PubMed ID: 31449673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative analysis of genomic aberrations associated with prostate cancer progression.
    Kim JH; Dhanasekaran SM; Mehra R; Tomlins SA; Gu W; Yu J; Kumar-Sinha C; Cao X; Dash A; Wang L; Ghosh D; Shedden K; Montie JE; Rubin MA; Pienta KJ; Shah RB; Chinnaiyan AM
    Cancer Res; 2007 Sep; 67(17):8229-39. PubMed ID: 17804737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
    Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
    Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of genomic alterations through coregulation analysis of closely linked genes: a frequent gain in 17q25.3 in prostate cancer.
    Bermudo R; Abia D; Benitez D; Carrió A; Vilella R; Ortiz AR; Thomson TM; Fernández PL
    Ann N Y Acad Sci; 2010 Oct; 1210():17-24. PubMed ID: 20973795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of novel amplicons in prostate cancer by comprehensive genomic profiling of prostate cancer cell lines using oligonucleotide-based arrayCGH.
    Kamradt J; Jung V; Wahrheit K; Tolosi L; Rahnenfuehrer J; Schilling M; Walker R; Davis S; Stoeckle M; Meltzer P; Wullich B
    PLoS One; 2007 Aug; 2(8):e769. PubMed ID: 17712417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer.
    van Duin M; van Marion R; Vissers K; Watson JE; van Weerden WM; Schröder FH; Hop WC; van der Kwast TH; Collins C; van Dekken H
    Genes Chromosomes Cancer; 2005 Dec; 44(4):438-49. PubMed ID: 16130124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor interaction analysis for chromosome 8 and DNA methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer.
    Schulz WA; Alexa A; Jung V; Hader C; Hoffmann MJ; Yamanaka M; Fritzsche S; Wlazlinski A; Müller M; Lengauer T; Engers R; Florl AR; Wullich B; Rahnenführer J
    Mol Cancer; 2007 Feb; 6():14. PubMed ID: 17280610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular alterations in primary prostate cancer after androgen ablation therapy.
    Best CJ; Gillespie JW; Yi Y; Chandramouli GV; Perlmutter MA; Gathright Y; Erickson HS; Georgevich L; Tangrea MA; Duray PH; González S; Velasco A; Linehan WM; Matusik RJ; Price DK; Figg WD; Emmert-Buck MR; Chuaqui RF
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6823-34. PubMed ID: 16203770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of new DNA amplification loci in prostate cancer by comparative genomic hybridization.
    El Gedaily A; Bubendorf L; Willi N; Fu W; Richter J; Moch H; Mihatsch MJ; Sauter G; Gasser TC
    Prostate; 2001 Feb; 46(3):184-90. PubMed ID: 11170146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal aberrations in prostate cancer xenografts detected by comparative genomic hybridization.
    Laitinen S; Karhu R; Sawyers CL; Vessella RL; Visakorpi T
    Genes Chromosomes Cancer; 2002 Sep; 35(1):66-73. PubMed ID: 12203791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.
    Jiang M; Li M; Fu X; Huang Y; Qian H; Sun R; Mao Y; Xie Y; Li Y
    Prostate; 2008 Oct; 68(14):1496-509. PubMed ID: 18366025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer.
    Kumar A; Coleman I; Morrissey C; Zhang X; True LD; Gulati R; Etzioni R; Bolouri H; Montgomery B; White T; Lucas JM; Brown LG; Dumpit RF; DeSarkar N; Higano C; Yu EY; Coleman R; Schultz N; Fang M; Lange PH; Shendure J; Vessella RL; Nelson PS
    Nat Med; 2016 Apr; 22(4):369-78. PubMed ID: 26928463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution genomic profiling of occult micrometastatic tumor cells.
    Kraus J; Pantel K; Pinkel D; Albertson DG; Speicher MR
    Genes Chromosomes Cancer; 2003 Feb; 36(2):159-66. PubMed ID: 12508244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.